Company intelligence / Profile preview
ReLive Biotechnologies
Boston, Massachusetts, USArelivebio.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
ReLive’s lead product, Spherox, is an autologous cell therapy for knee cartilage repair approved by the European Medicines Agency. Over 19,000 patients have been treated with its spheroid-based approach. Clinical efficacy and safety have been demonstrated in Phase II/III trials. In December 2023, SpheChon was approved as Singapore’s first cell therapy for cartilage repair.[1][2][8] The company continues to develop next-generation universal allogeneic versions.
- Therapeutic areas
- OtherRheumatologyOrthopedics
- Modalities
- Autologous cell therapies (using patient’s own cells)Spheroid technology (3D spheroids of cartilage cells)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Academic collaborations with Harvard University and MIT on advanced cell/gene therapies and scaffold materials[4].
Beyond the preview
Go deeper on ReLive Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReLive Biotechnologies.